Skip to main content
Joshua Reicher, MD, Radiology, Palo Alto, CA

Joshua Jay Reicher MD


Radiology Resident / PGY-2

Join to View Full Profile
  • 3801 Miranda AvePalo Alto, CA 94304

  • Phone+1 650-493-5000

Dr. Reicher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • I am a physician and healthcare entrepreneur, seeking to transform our healthcare system through improved workflow, advanced technology, and innovative ideas.

    Outside of my clinical practice, I operate the organization Health Companion (www.healthcompanion.com). Health Companion is a healthcare social network site to store, manage, and communicate your health information with providers, insurance companies, employers, family, and friends as you see appropriate. You can maintain a life-long Personal Health Record, track medical expenses, manage health finances, and monitor preventive health & wellness activities.

Education & Training

  • Santa Clara Valley Medical Center
    Santa Clara Valley Medical CenterInternship, Internal Medicine, 2012
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Radiology-Diagnostic, 2013 - 2017
  • University of California San Diego School of Medicine
    University of California San Diego School of MedicineClass of 2012
  • UC Los Angeles
    UC Los AngelesBS, Biophysics, Summa Cum Laude, 2004 - 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2026
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology

Publications & Presentations

PubMed

Press Mentions

  • IMVARIA Announces Data Demonstrating Company’s Non-Invasive Digital Biomarker for Predicting Mortality in Interstitial Lung Diseases
    IMVARIA Announces Data Demonstrating Company’s Non-Invasive Digital Biomarker for Predicting Mortality in Interstitial Lung DiseasesMay 21st, 2023
  • Aiming Precision Medicine at Chronic Diseases
    Aiming Precision Medicine at Chronic DiseasesAugust 16th, 2022
  • Digital Biomarker Tool for Rapidly Identifying Lung Fibrosis Cleared by FDA
    Digital Biomarker Tool for Rapidly Identifying Lung Fibrosis Cleared by FDAJanuary 19th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: